Shantou Institute of Ultrasonic Instrument
301602
Hubei Sinophorus Electronic Materials
688545
Pansoft
300996
Jiayu Holding
300117
Wuxi Taclink Optoelectronics Technology
688205
CN Stock MarketDetailed Quotes
688073 Bide Pharmatech
- 48.48
- 0.000.00%
Market Closed Jan 13 15:00 CST
4.41BMarket Cap55.03P/E (TTM)
0.00High0.00Low0lotVolume0.00Open48.48Pre Close0.00Turnover0.00%Turnover Ratio40.20P/E (Static)90.88MShares53.2852wk High2.21P/B2.10BFloat Cap28.5052wk Low58.18Limit Up43.23MShs Float112.07Historical High38.78Limit Down0.00%Amplitude28.50Historical Low0.90Dividend TTM--Avg Price0lotAsk1.86%Div YieldTTM100Lot Size0lotBid
Bide Pharmatech News
Bide Pharmaceutical: Announcement on the progress of planning to issue shares to purchase assets and the continued suspension of trading
Bide Pharmaceutical: Notice on suspension of trading on planning to issue shares to purchase assets and raise supporting capital
Bide Pharmaceutical: Bide Pharmaceutical: List of incentive recipients granted for the first time in the company\'s 2024 restricted stock incentive plan (as of the grant date)
Bide Pharmaceuticals: Bide Pharmaceutical: Supervisory Board\'s Review Opinions on the List of Incentive Recipients Granted for the First Time under the 2024 Restricted Stock Incentive Plan (as of the grant date)
Bide Pharmaceutical: Independent Financial Advisory Report of Shanghai Xingong Yihe Enterprise Management Consulting Co., Ltd. on matters relating to the first grant of the 2024 Restricted Stock Incentive Plan to Shanghai Bide Pharmaceutical Technology Co., Ltd.
Bide Pharmaceutical: Announcement on granting restricted shares to incentive recipients for the first time
Bide Pharmaceutical: Legal Opinion of Shanghai Junlan Law Firm on matters relating to the first granting of restricted shares in Bide Pharmaceutical\'s 2024 Incentive Plan
Bide Pharmaceutical: Supervisory Board\'s Review Opinions on the List of Incentives Granted for the First Time under the 2024 Restricted Stock Incentive Plan (as of the grant date)
Announcement on granting restricted shares to incentive recipients for the first time
Bide Pharmaceutical: List of incentive recipients granted for the first time in the company\'s 2024 restricted stock incentive plan (as of the grant date)
Legal Opinion of Shanghai Junlan Law Firm on matters relating to the first granting of restricted shares in Bide Pharmaceutical\'s 2024 Incentive Plan
Bide Pharmaceutical: Self-inspection report on the 2024 Restricted Stock Incentive Plan insider\'s stock trading situation
Self-inspection report on the 2024 Restricted Stock Incentive Plan insider\'s stock trading situation
Bide Pharmaceutical: Explanation of the review opinions and disclosure of the supervisory board of Shanghai Bide Pharmaceutical Technology Co., Ltd. on the list of incentive recipients granted for the first time in the company\'s 2024 restricted stock incentive plan
Explanation of the review opinions and publicity of the board of supervisors of Shanghai Bide Pharmaceutical Technology Co., Ltd. on the list of incentive recipients granted for the first time in the company\'s 2024 restricted stock incentive plan
Bide Pharmaceuticals: Bide Pharmaceuticals: 2024 Restricted Stock Incentive Plan (Draft)
Bide Pharmaceuticals: 2024 Restricted Stock Incentive Plan (Draft)
The Company\'s 2024 Restricted Stock Incentive Plan granted a list of incentive recipients for the first time
Supervisory Board\'s Review Opinions on the Company\'s 2024 Restricted Stock Incentive Plan (Draft)
Legal Opinion of Shanghai Junlan Law Firm on Bidet Pharmaceuticals 2024 Restricted Stock Incentive Plan (Draft)
